The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 137 participants.

Also called NCT06649773

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 137 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06649773
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06649773. Randomized; quadruple masking; primary purpose treatment. Start 2024-11-06 (actual); primary completion 2025-05-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients
Intervention (Drug)
Noiiglutide Injection
Intervention (Drug)
Noiiglutide Placebo
Lead sponsor
Jiangsu HengRui Medicine Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct06649773
Content hash
3a9471d69f43643d6b6d58c70b2084149b343ac1b1d487a91bfd709c7282428f